Transitional Cell Cancer of the Renal Pelvis and Ureter
📧 Sign up to get email alerts when something new happens for Transitional Cell Cancer of the Renal Pelvis and Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating pemetrexed disodium and gemcitabine in advanced urothelial cancers (bladder cancer and transitional cell cancers of…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for advanced urothelial cancer with decreased kidney function has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
Phase 2 clinical trial evaluating piritrexim in advanced urinary tract cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and gemcitabine in progressive regional or metastatic bladder cancer and related transitional cell cancer…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract [Phase 2]
Phase 2 trial evaluating surgery plus combination chemotherapy and radiation therapy for cancer of the urinary tract (bladder cancer and rel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-05-07Clinical Trial Update: Efficacy and Safety of UGN-101 in Recurrent Patients [Phase 3]
Phase 3 trial of UGN-101 for recurrent carcinoma variants has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium [Phase 1, Phase 2]
A Phase 1/2 trial investigating gemcitabine hydrochloride, cisplatin, and temsirolimus as first-line therapy for locally advanced or metasta…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bortezomib in patients with advanced or metastatic transitio…
-
CLINICAL_TRIALS research · 2013-06-28Clinical Trial Update: Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer [Phase 1]
This Phase 1 clinical trial evaluated combination chemotherapy following surgery in patients with advanced bladder cancer and related urothe…